| Year |
Citation |
Score |
| 2023 |
Kelly L, Brown C, Michalik D, Hawkes CA, Aldea R, Agarwal N, Salib R, Alzetani A, Ethell DW, Counts SE, de Leon M, Fossati S, Koronyo-Hamaoui M, Piazza F, Rich SA, et al. Clearance of interstitial fluid (ISF) and CSF (CLIC) group-part of Vascular Professional Interest Area (PIA), updates in 2022-2023. Cerebrovascular disease and the failure of elimination of Amyloid-β from the brain and retina with age and Alzheimer's disease: Opportunities for therapy. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 37897797 DOI: 10.1002/alz.13512 |
0.393 |
|
| 2023 |
Ramirez E, Ganegamage SK, Min S, Patel H, Ogunware A, Plascencia-Villa G, Alnakhala H, Shimanaka K, Tripathi A, Wang KW, Zhu X, Rochet JC, Kuo MH, Counts SE, Perry G, et al. Evaluation of N- and O-Linked Indole Triazines for a Dual Effect on α-Synuclein and Tau Aggregation. Acs Chemical Neuroscience. PMID 37818657 DOI: 10.1021/acschemneuro.3c00464 |
0.599 |
|
| 2023 |
Ehrenberg AJ, Kelberman MA, Liu KY, Dahl MJ, Weinshenker D, Falgàs N, Dutt S, Mather M, Ludwig M, Betts MJ, Winer JR, Teipel S, Weigand AJ, Eschenko O, Hämmerer D, ... ... Counts SE, et al. Priorities for research on neuromodulatory subcortical systems in Alzheimer's disease: Position paper from the NSS PIA of ISTAART. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 36642985 DOI: 10.1002/alz.12937 |
0.535 |
|
| 2022 |
Fortin JS, Shimanaka K, Saraswati AP, Liu M, Wang KW, Hagar HT, Maity S, Ganegamage SK, Ellsworth E, Counts SE, Borhan B, Dettmer U, Kuo MH. Anti-fibrillization effects of sulfonamide derivatives on -synuclein and hyperphosphorylated tau isoform 1N4R. Journal of Molecular Structure. 1267. PMID 36310922 DOI: 10.1016/j.molstruc.2022.133574 |
0.6 |
|
| 2022 |
Wang R, Chopra N, Nho K, Maloney B, Obukhov AG, Nelson PT, Counts SE, Lahiri DK. Human microRNA (miR-20b-5p) modulates Alzheimer's disease pathways and neuronal function, and a specific polymorphism close to the MIR20B gene influences Alzheimer's biomarkers. Molecular Psychiatry. PMID 35087196 DOI: 10.1038/s41380-021-01351-3 |
0.331 |
|
| 2020 |
Carare RO, Aldea R, Agarwal N, Bacskai BJ, Bechman I, Boche D, Bu G, Bulters D, Clemens A, Counts SE, de Leon M, Eide PK, Fossati S, Greenberg SM, Hamel E, et al. Clearance of interstitial fluid (ISF) and CSF (CLIC) group-part of Vascular Professional Interest Area (PIA): Cerebrovascular disease and the failure of elimination of Amyloid-β from the brain and retina with age and Alzheimer's disease-Opportunities for Therapy. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12053. PMID 32775596 DOI: 10.1002/Dad2.12053 |
0.339 |
|
| 2020 |
Chopra N, Wang R, Maloney B, Nho K, Beck JS, Pourshafie N, Niculescu A, Saykin AJ, Rinaldi C, Counts SE, Lahiri DK. MicroRNA-298 reduces levels of human amyloid-β precursor protein (APP), β-site APP-converting enzyme 1 (BACE1) and specific tau protein moieties. Molecular Psychiatry. PMID 31942037 DOI: 10.1038/S41380-019-0610-2 |
0.427 |
|
| 2019 |
Ginsberg SD, Malek-Ahmadi MH, Alldred MJ, Chen Y, Chen K, Chao MV, Counts SE, Mufson EJ. Brain-derived neurotrophic factor (BDNF) and TrkB hippocampal gene expression are putative predictors of neuritic plaque and neurofibrillary tangle pathology. Neurobiology of Disease. 104540. PMID 31349032 DOI: 10.1016/J.Nbd.2019.104540 |
0.398 |
|
| 2019 |
Mufson EJ, Counts SE, Ginsberg SD, Mahady L, Perez SE, Massa SM, Longo FM, Ikonomovic MD. Nerve Growth Factor Pathobiology During the Progression of Alzheimer's Disease. Frontiers in Neuroscience. 13: 533. PMID 31312116 DOI: 10.3389/fnins.2019.00533 |
0.396 |
|
| 2019 |
Kelly SC, McKay EC, Beck JS, Collier TJ, Dorrance AM, Counts SE. Locus Coeruleus Degeneration Induces Forebrain Vascular Pathology in a Transgenic Rat Model of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 31177220 DOI: 10.3233/Jad-190090 |
0.338 |
|
| 2019 |
Gordon MN, Beck JS, Kanaan NM, Winn ME, Ginsberg SD, Counts SE. P3-173: MICROARRAY ANALYSES REVEAL SENESCENCE-ASSOCIATED GENE EXPRESSION IN ALZHEIMER'S DISEASE AND TRANSGENIC MOUSE MODELS WITH AMYLOID DEPOSITION OR TAUOPATHY Alzheimer's & Dementia. 15: P996-P997. DOI: 10.1016/J.Jalz.2019.06.3202 |
0.371 |
|
| 2018 |
Vega IE, Umstead A, Wygant CM, Beck JS, Counts SE. Ezrin expression is increased during disease progression in a tauopathy mouse model and Alzheimer's disease. Current Alzheimer Research. PMID 30101710 DOI: 10.2174/1567205015666180813152043 |
0.383 |
|
| 2018 |
Tiernan CT, Ginsberg SD, He B, Ward SM, Guillozet-Bongaarts AL, Kanaan NM, Mufson EJ, Counts SE. Pretangle pathology within cholinergic nucleus basalis neurons coincides with neurotrophic and neurotransmitter receptor gene dysregulation during the progression of Alzheimer's disease. Neurobiology of Disease. PMID 29859871 DOI: 10.1016/J.Nbd.2018.05.021 |
0.348 |
|
| 2018 |
Tiernan CT, Mufson EJ, Kanaan NM, Counts SE. Tau Oligomer Pathology in Nucleus Basalis Neurons During the Progression of Alzheimer Disease. Journal of Neuropathology and Experimental Neurology. PMID 29378005 DOI: 10.1093/Jnen/Nlx120 |
0.457 |
|
| 2017 |
Ginsberg SD, Malek-Ahmadi MH, Alldred MJ, Che S, Elarova I, Chen Y, Jeanneteau F, Kranz TM, Chao MV, Counts SE, Mufson EJ. Selective decline of neurotrophin and neurotrophin receptor genes within CA1 pyramidal neurons and hippocampus proper: Correlation with cognitive performance and neuropathology in mild cognitive impairment and Alzheimer's disease. Hippocampus. PMID 28888073 DOI: 10.1002/Hipo.22802 |
0.312 |
|
| 2017 |
Vega IE, Cabrera LY, Wygant CM, Velez-Ortiz D, Counts SE. Alzheimer's Disease in the Latino Community: Intersection of Genetics and Social Determinants of Health. Journal of Alzheimer's Disease : Jad. PMID 28527211 DOI: 10.3233/JAD-161261 |
0.319 |
|
| 2017 |
Kelly SC, He B, Perez SE, Ginsberg SD, Mufson EJ, Counts SE. Locus coeruleus cellular and molecular pathology during the progression of Alzheimer's disease. Acta Neuropathologica Communications. 5: 8. PMID 28109312 DOI: 10.1186/s40478-017-0411-2 |
0.323 |
|
| 2017 |
Counts SE, Mufson EJ. Regulator of Cell Cycle (RGCC) Expression During the Progression of Alzheimer's Disease. Cell Transplantation. 26: 693-702. PMID 27938491 DOI: 10.3727/096368916X694184 |
0.357 |
|
| 2016 |
Counts SE, Ikonomovic MD, Mercado N, Vega IE, Mufson EJ. Biomarkers for the Early Detection and Progression of Alzheimer's Disease. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 27738903 DOI: 10.1007/s13311-016-0481-z |
0.385 |
|
| 2016 |
Tiernan CT, Combs B, Cox K, Morfini G, Brady ST, Counts SE, Kanaan NM. Pseudophosphorylation of tau at S422 enhances SDS-stable dimer formation and impairs both anterograde and retrograde fast axonal transport. Experimental Neurology. PMID 27373205 DOI: 10.1016/J.Expneurol.2016.06.030 |
0.531 |
|
| 2016 |
Mufson EJ, Ikonomovic MD, Counts SE, Perez SE, Malek-Ahmadi M, Scheff SW, Ginsberg SD. Molecular and Cellular Pathophysiology of Preclinical Alzheimer's Disease. Behavioural Brain Research. PMID 27185734 DOI: 10.1016/J.Bbr.2016.05.030 |
0.467 |
|
| 2016 |
Tiernan CT, Ginsberg SD, Guillozet-Bongaarts AL, Ward SM, He B, Kanaan NM, Mufson EJ, Binder LI, Counts SE. Protein homeostasis gene dysregulation in pretangle-bearing nucleus basalis neurons during the progression of Alzheimer's disease. Neurobiology of Aging. 42: 80-90. PMID 27143424 DOI: 10.1016/J.Neurobiolaging.2016.02.031 |
0.436 |
|
| 2016 |
Counts SE, He B, Prout JG, Michalski B, Farotti L, Fahnestock M, Mufson EJ. Cerebrospinal fluid proNGF: A putative biomarker for early Alzheimer's disease. Current Alzheimer Research. PMID 26825093 DOI: 10.2174/1567205013666160129095649 |
0.428 |
|
| 2015 |
Mufson EJ, Mahady L, Waters D, Counts SE, Perez SE, DeKosky ST, Ginsberg SD, Ikonomovic MD, Scheff SW, Binder LI. Hippocampal plasticity during the progression of Alzheimer's disease. Neuroscience. PMID 25772787 DOI: 10.1016/J.Neuroscience.2015.03.006 |
0.403 |
|
| 2014 |
Counts SE, Perez SE, He B, Mufson EJ. Intravenous immunoglobulin reduces tau pathology and preserves neuroplastic gene expression in the 3xTg mouse model of Alzheimer's disease. Current Alzheimer Research. 11: 655-63. PMID 25156574 |
0.372 |
|
| 2014 |
Counts SE, Lahiri DK. Overview of immunotherapy in Alzheimer's disease (AD) and mechanisms of IVIG neuroprotection in preclinical models of AD. Current Alzheimer Research. 11: 623-5. PMID 25156573 DOI: 10.2174/156720501107140815102453 |
0.392 |
|
| 2014 |
Counts SE, Ray B, Mufson EJ, Perez SE, He B, Lahiri DK. Intravenous immunoglobulin (IVIG) treatment exerts antioxidant and neuropreservatory effects in preclinical models of Alzheimer's disease. Journal of Clinical Immunology. 34: S80-5. PMID 24760109 DOI: 10.1007/S10875-014-0020-9 |
0.322 |
|
| 2014 |
Counts SE, Alldred MJ, Che S, Ginsberg SD, Mufson EJ. Synaptic gene dysregulation within hippocampal CA1 pyramidal neurons in mild cognitive impairment. Neuropharmacology. 79: 172-9. PMID 24445080 DOI: 10.1016/J.Neuropharm.2013.10.018 |
0.319 |
|
| 2013 |
Counts S, Perez S, Mufson E. P2-031: IVIG reduces tau pathology and increases neuroplastic gene expression in the 3xTg mouse model of Alzheimer's disease Alzheimer's & Dementia. 9: P356-P356. DOI: 10.1016/j.jalz.2013.05.673 |
0.416 |
|
| 2012 |
Mufson EJ, He B, Nadeem M, Perez SE, Counts SE, Leurgans S, Fritz J, Lah J, Ginsberg SD, Wuu J, Scheff SW. Hippocampal proNGF signaling pathways and β-amyloid levels in mild cognitive impairment and Alzheimer disease. Journal of Neuropathology and Experimental Neurology. 71: 1018-29. PMID 23095849 DOI: 10.1097/Nen.0B013E318272Caab |
0.394 |
|
| 2012 |
Perez SE, Nadeem M, Sadleir KR, Matras J, Kelley CM, Counts SE, Vassar R, Mufson EJ. Dimebon alters hippocampal amyloid pathology in 3xTg-AD mice. International Journal of Physiology, Pathophysiology and Pharmacology. 4: 115-27. PMID 23071869 |
0.399 |
|
| 2012 |
Perez SE, Getova DP, He B, Counts SE, Geula C, Desire L, Coutadeur S, Peillon H, Ginsberg SD, Mufson EJ. Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease. The American Journal of Pathology. 180: 526-40. PMID 22142809 DOI: 10.1016/J.Ajpath.2011.10.027 |
0.438 |
|
| 2012 |
Mufson E, Counts S, Ikonomovic M. 55 Cholinergic and amyloid activity in prodromal AD: implications for disease treatment Neurobiology of Aging. 33: S24. DOI: 10.1016/j.neurobiolaging.2012.01.073 |
0.38 |
|
| 2011 |
Ginsberg SD, Mufson EJ, Alldred MJ, Counts SE, Wuu J, Nixon RA, Che S. Upregulation of select rab GTPases in cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer's disease. Journal of Chemical Neuroanatomy. 42: 102-10. PMID 21669283 DOI: 10.1016/J.Jchemneu.2011.05.012 |
0.375 |
|
| 2011 |
Counts SE, Che S, Ginsberg SD, Mufson EJ. Gender differences in neurotrophin and glutamate receptor expression in cholinergic nucleus basalis neurons during the progression of Alzheimer's disease. Journal of Chemical Neuroanatomy. 42: 111-7. PMID 21397006 DOI: 10.1016/j.jchemneu.2011.02.004 |
0.354 |
|
| 2010 |
Counts SE, Mufson EJ. PUTATIVE CSF PROTEIN BIOMARKER CANDIDATES FOR AMNESTIC MILD COGNITIVE IMPAIRMENT. Translational Neuroscience. 1: 2-8. PMID 21311725 DOI: 10.2478/v10134-010-0004-0 |
0.312 |
|
| 2010 |
Counts SE, Perez SE, Ginsberg SD, Mufson EJ. Neuroprotective role for galanin in Alzheimer's disease. Exs. 102: 143-62. PMID 21299067 DOI: 10.1007/978-3-0346-0228-0_11 |
0.394 |
|
| 2010 |
Ginsberg SD, Mufson EJ, Counts SE, Wuu J, Alldred MJ, Nixon RA, Che S. Regional selectivity of rab5 and rab7 protein upregulation in mild cognitive impairment and Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 22: 631-9. PMID 20847427 DOI: 10.3233/Jad-2010-101080 |
0.375 |
|
| 2010 |
Ginsberg SD, Alldred MJ, Counts SE, Cataldo AM, Neve RL, Jiang Y, Wuu J, Chao MV, Mufson EJ, Nixon RA, Che S. Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer's disease progression. Biological Psychiatry. 68: 885-93. PMID 20655510 DOI: 10.1016/J.Biopsych.2010.05.030 |
0.351 |
|
| 2010 |
Mufson EJ, Wuu J, Counts SE, Nykjaer A. Preservation of cortical sortilin protein levels in MCI and Alzheimer's disease. Neuroscience Letters. 471: 129-33. PMID 20085800 DOI: 10.1016/j.neulet.2010.01.023 |
0.356 |
|
| 2009 |
Counts SE, He B, Che S, Ginsberg SD, Mufson EJ. Galanin fiber hyperinnervation preserves neuroprotective gene expression in cholinergic basal forebrain neurons in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 18: 885-96. PMID 19749437 DOI: 10.3233/JAD-2009-1196 |
0.377 |
|
| 2009 |
Ikonomovic MD, Wecker L, Abrahamson EE, Wuu J, Counts SE, Ginsberg SD, Mufson EJ, Dekosky ST. Cortical alpha7 nicotinic acetylcholine receptor and beta-amyloid levels in early Alzheimer disease. Archives of Neurology. 66: 646-51. PMID 19433665 DOI: 10.1001/Archneurol.2009.46 |
0.352 |
|
| 2008 |
Mufson EJ, Counts SE, Perez SE, Ginsberg SD. Cholinergic system during the progression of Alzheimer's disease: therapeutic implications. Expert Review of Neurotherapeutics. 8: 1703-18. PMID 18986241 DOI: 10.1586/14737175.8.11.1703 |
0.399 |
|
| 2008 |
Counts SE, Perez SE, Mufson EJ. Galanin in Alzheimer's disease: neuroinhibitory or neuroprotective? Cellular and Molecular Life Sciences : Cmls. 65: 1842-53. PMID 18500641 DOI: 10.1007/s00018-008-8159-2 |
0.391 |
|
| 2008 |
Counts SE, He B, Che S, Ginsberg SD, Mufson EJ. Galanin hyperinnervation upregulates choline acetyltransferase expression in cholinergic basal forebrain neurons in Alzheimer's disease. Neuro-Degenerative Diseases. 5: 228-31. PMID 18322398 DOI: 10.1159/000113710 |
0.36 |
|
| 2007 |
Counts SE, He B, Che S, Ikonomovic MD, DeKosky ST, Ginsberg SD, Mufson EJ. Alpha7 nicotinic receptor up-regulation in cholinergic basal forebrain neurons in Alzheimer disease. Archives of Neurology. 64: 1771-6. PMID 18071042 DOI: 10.1001/Archneur.64.12.1771 |
0.338 |
|
| 2007 |
Mufson EJ, Counts SE, Fahnestock M, Ginsberg SD. Cholinotrophic molecular substrates of mild cognitive impairment in the elderly. Current Alzheimer Research. 4: 340-50. PMID 17908035 DOI: 10.2174/156720507781788855 |
0.441 |
|
| 2006 |
Ginsberg SD, Che S, Counts SE, Mufson EJ. Single cell gene expression profiling in Alzheimer's disease. Neurorx : the Journal of the American Society For Experimental Neurotherapeutics. 3: 302-18. PMID 16815214 DOI: 10.1016/j.nurx.2006.05.007 |
0.332 |
|
| 2006 |
Ginsberg SD, Che S, Wuu J, Counts SE, Mufson EJ. Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease. Journal of Neurochemistry. 97: 475-87. PMID 16539663 DOI: 10.1111/j.1471-4159.2006.03764.x |
0.362 |
|
| 2006 |
Ginsberg SD, Che S, Counts SE, Mufson EJ. Shift in the ratio of three-repeat tau and four-repeat tau mRNAs in individual cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer's disease. Journal of Neurochemistry. 96: 1401-8. PMID 16478530 DOI: 10.1111/j.1471-4159.2005.03641.x |
0.427 |
|
| 2006 |
Counts SE, Chen EY, Che S, Ikonomovic MD, Wuu J, Ginsberg SD, Dekosky ST, Mufson EJ. Galanin fiber hypertrophy within the cholinergic nucleus basalis during the progression of Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 21: 205-14. PMID 16410678 DOI: 10.1159/000090906 |
0.314 |
|
| 2006 |
Kelly SC, Nelson PT, Counts SE. P1-003: NORADRENERGIC MECHANISMS OF VASCULAR AND NEURONAL PATHOPHYSIOLOGY IN PRECLINICAL ALZHEIMER'S DISEASE Alzheimer's & Dementia. 14: P262-P262. DOI: 10.1016/j.jalz.2018.06.004 |
0.313 |
|
| 2005 |
Mufson EJ, Counts SE, Perez SE, Binder L. Galanin plasticity in the cholinergic basal forebrain in Alzheimer's disease and transgenic mice. Neuropeptides. 39: 233-7. PMID 15893372 DOI: 10.1016/J.Npep.2004.12.005 |
0.426 |
|
| 2005 |
Counts SE, Mufson EJ. The role of nerve growth factor receptors in cholinergic basal forebrain degeneration in prodromal Alzheimer disease. Journal of Neuropathology and Experimental Neurology. 64: 263-72. PMID 15835262 |
0.343 |
|
| 2004 |
Counts SE, Nadeem M, Wuu J, Ginsberg SD, Saragovi HU, Mufson EJ. Reduction of cortical TrkA but not p75(NTR) protein in early-stage Alzheimer's disease. Annals of Neurology. 56: 520-31. PMID 15455399 DOI: 10.1002/Ana.20233 |
0.36 |
|
| 2003 |
Counts SE, Perez SE, Ginsberg SD, De Lacalle S, Mufson EJ. Galanin in Alzheimer disease. Molecular Interventions. 3: 137-56. PMID 14993421 DOI: 10.1124/mi.3.3.137 |
0.405 |
|
| 2003 |
Mufson EJ, Ikonomovic MD, Styren SD, Counts SE, Wuu J, Leurgans S, Bennett DA, Cochran EJ, DeKosky ST. Preservation of brain nerve growth factor in mild cognitive impairment and Alzheimer disease. Archives of Neurology. 60: 1143-8. PMID 12925373 DOI: 10.1001/Archneur.60.8.1143 |
0.336 |
|
| 2002 |
Mufson EJ, Counts SE, Ginsberg SD. Gene expression profiles of cholinergic nucleus basalis neurons in Alzheimer's disease. Neurochemical Research. 27: 1035-48. PMID 12462403 DOI: 10.1023/A:1020952704398 |
0.376 |
|
| 2001 |
Counts SE, Perez SE, Kahl U, Bartfai T, Bowser RP, Deecher DC, Mash DC, Crawley JN, Mufson EJ. Galanin: neurobiologic mechanisms and therapeutic potential for Alzheimer's disease. Cns Drug Reviews. 7: 445-70. PMID 11830760 DOI: 10.1111/J.1527-3458.2001.Tb00210.X |
0.332 |
|
| 2001 |
Jaffar S, Counts SE, Ma SY, Dadko E, Gordon MN, Morgan D, Mufson EJ. Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway. Experimental Neurology. 170: 227-43. PMID 11476589 DOI: 10.1006/Exnr.2001.7710 |
0.371 |
|
| 2001 |
Counts SE, Lah JJ, Levey AI. The regulation of presenilin-1 by nerve growth factor. Journal of Neurochemistry. 76: 679-89. PMID 11158238 DOI: 10.1046/J.1471-4159.2001.00014.X |
0.46 |
|
| 1998 |
Gilmor ML, Counts SE, Wiley RG, Levey AI. Coordinate expression of the vesicular acetylcholine transporter and choline acetyltransferase following septohippocampal pathway lesions. Journal of Neurochemistry. 71: 2411-20. PMID 9832139 DOI: 10.1046/J.1471-4159.1998.71062411.X |
0.416 |
|
| 1997 |
Lah JJ, Heilman CJ, Nash NR, Rees HD, Yi H, Counts SE, Levey AI. Light and electron microscopic localization of presenilin-1 in primate brain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 1971-80. PMID 9045726 DOI: 10.1523/Jneurosci.17-06-01971.1997 |
0.485 |
|
| Show low-probability matches. |